Iara S. Rodrigues
Agulha, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Prognostic value of GRIM-19, NF-κB and IKK2 in patients with high-grade serous ovarian cancer.
Journal: Pathology, research and practice
Published: September 27, 2017
MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression.
Journal: Oncotarget
Published: January 11, 2016
An Integrative Approach Uncovers Biomarkers that Associate with Clinically Relevant Disease Outcomes in Vulvar Carcinoma.
Journal: Molecular cancer research : MCR
Published: August 27, 2015
EGFR expression in vulvar cancer: clinical implications and tumor heterogeneity.
Journal: Human pathology
Published: November 26, 2013
Cell cycle suppressor proteins are not related to HPV status or clinical outcome in patients with vulvar carcinoma.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: March 28, 2013
Epithelial-mesenchymal transition-like events in vulvar cancer and its relation with HPV.
Journal: British journal of cancer
Published: February 12, 2013
Does the count after inguinofemoral lymphadenectomy in vulvar cancer correlate with outcome?
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: May 12, 2012
Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside.
Journal: Journal of translational medicine
Published: May 02, 2012
Prognostication of vulvar cancer based on p14ARF status: molecular assessment of transcript and protein.
Journal: Annals of surgical oncology
Published: February 17, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026